Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention

Ítems similars

• Development and validation of a Bayesian index for predicting major adverse cardiac events with percutaneous transluminal coronary angioplasty
  per: de Belder, A J, et al.
  Publicat: (2001)
• Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England
  per: Grayson, A D, et al.
  Publicat: (2006)
• Hallucinations as an adverse effect of angiotensin converting enzyme inhibition.
  per: Haffner, C. A., et al.
  Publicat: (1993)
• Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release
  per: Brull, D J, et al.
  Publicat: (2002)
• Lung Cancer Adverse Events Reports for Angiotensin-Converting Enzyme Inhibitors: Data Mining of the FDA Adverse Event Reporting System Database
  per: Meng, Long, et al.
  Publicat: (2021)